Skip to content
Visit one of our cancer information centres
Select A Cancer
Cancer Of The Cervix
Cancer Of The Pancreas
Colon And Rectal Cancer
Head And Neck Cancer
Myeloma And Plasmacytoma
Non Hodgkin's Lymphoma
Soft Tissue Sarcomas
Stomach Cancer (Gastric Cancer)
Search the site
In this section...
Questions and answers
Glossary of terms
On this site...
Current issues in kidney cancer
Current issues highlight some of the latest research into kidney cancer, new therapies becoming available and new drug treatments coming to the market.
High dose Interleukin-2 (hd Il-2) versus low dose Il-2 plus Interferon in metastatic renal/kidney cancer
Optimisation of immunotherapy for metastatic renal cancer is a 'work in progress' subject. At this year's American Society of Clinical Oncology meeting, data from Boston were presented suggesting a...
Nephrectomy followed by Interferon versus Interferon alone as therapy of metastatic kidney cancer
It has been established that immunotherapy (interferon or interferon plus other) is the best systemic therapy for kidney/renal cancer that has metastasised. In the past there had been recorded...
Sunitinib therapy in kidney cancer
A recent study presented at the American Society for Clinical Oncology annual meeting, compared therapy with sunitinib (an inhibitor of the effector pathway of the VHL oncogene)with interferon...
Intuition Communication Ltd., 3 Churchgates, Wilderness, Berkhamsted, Hertfordshire HP4 2UB
Copyright © 2005 - 2016 Intuition Communication Ltd. All Rights Reserved.
Visit our other websites
connect with us
through our blogs, forums and other social media.